Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
San Qi oral liquid is a traditional Chinese medicine (TCM) preparation derived from the roots of *Panax notoginseng* (San Qi). It is primarily utilized in integrative medicine regimens for the treatment of chronic kidney disease (CKD) and chronic renal failure. The drug is believed to exert therapeutic effects through anti-inflammatory, anti-fibrotic, and microcirculation-improving mechanisms, which help delay the progression of renal dysfunction. In clinical practice, particularly at institutions like the Guangdong Provincial Hospital of TCM, it is often used as part of a multi-modal clinical pathway that includes other TCM granules (e.g., NiaoDuQing) and procedures like colon dialysis to manage uremic symptoms and prolong the time to dialysis initiation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on San Qi oral liquid.